46057 (2024). Hon Dr Ayesha Verrall to the Minister of Health

Written Question

Published date: 12 Aug 2024

Metadata

Document type:	Written Question
Parliament number:	54
Question number:	46057 (2024)
Question asked:	29 Jul 2024
Member asking:	Hon Dr Ayesha Verrall
Portfolio:	Minister of Health
Minister replying:	Hon Dr Shane Reti
Answer received:	06 Aug 2024
Status:	Question Answered
Reply type:	Reply
Document ID:	WQ_46057_2024
Document guid:	fdee2c25-bde4-4bca-b776-5d8e14d490f6

46057 (2024). Hon Dr Ayesha Verrall to the Minister of Health: What progress, if any, has been made in the quarter January to March 2024 toward the action ‘Strengthen platforms for commercialising innovations’, under ‘Strategic Priority 4:’ within the Ministry of Health’s New Zealand Health Research Strategy 2017 – 2027?

Hon Dr Shane Reti: I am advised that during the quarter January to March 2024, Te Titoki Mataora (the MedTech Research Translator) hosted by the Auckland Bioengineering Institute on behalf of the Consortium for Medical Device Technologies, continued to focus on the commercialisation of research that addresses healthcare needs and improves the equity of access to care and outcomes. This included the Research Acceleration Programme that funds early-stage deep tech concepts which address an unmet clinical or health need and have commercial potential.